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Introduction
Macrophage activation syndrome (MAS) is a serious,
potentially fatal complication of rheumatic diseases,
which is seen most frequently in systemic onset juvenile
idiopathic arthritis (soJIA).
Objectives
This case is reported to expose the difficulties of diagno-
sis and management of MAS due to soJIA in a patient
with liver transplantation.
Methods
A 9-year-old girl (with a liver transplantation because of
biliar hypoplasia from her father at the age of five years)
presented with fever, rash and oligoarthiritis. An urgent
tube thoracostomy was performed because of severe
pleural effusion. She was transferred to the intensive care
unit with the diagnosis of sepsis. On admission, the
patient’s white blood cells (WBC) 31600/mm3, platelets
(plt) 40600/mm3, C reactive protein (CRP) 264 mg/dl
and liver enzymes was normal. Because of persistent
fever and pericardial effusion, bone marrow aspiration
was performed and revealed hemophagocytosis. Intrave-
nous methylprednisolone (IV) was administered at a dose
of 30 mg/kg/day for three days. Fever was reported to
subside and her treatment switched to oral methylpredni-
solone at a dose of 1.5 mg/kg/day. Maculopapular rash
and pericardial effusion persisted. At that time the
patient’s hemoglobin (Hb) was 9.2 g/dL, WBC 40900/
mm3, plt 151000/mm3, erythrocyte sedimentation rate
(ESR) 8 mm/h, CRP 8.26 mg/dl, fibrinogen 3.7 g/l, ala-
nine aminotransferase (ALT) 93 U/l, aspartate
aminotransferase (AST) 69 U/l. After four days, resistant
high fever relapsed and dexamethasone, etoposide and
IVIG added to her treatment. The dose of tacrolimus
given for liver transplantation was increased to 3 mg/day.
Results
When she was transferred to our clinic, physical exami-
nation was notable for temperature ranged from 40° C to
above and maculopapular rash. Echocardiography
revealed severe pericardial effusion. Hb was 6.1 g/dL,
WBC 12600/mm3, plt 21800/mm3, ESR 4 mm/h, CRP
0.68 mg/dl, fibrinogen 1.2 g/l, D-dimer 19.8 ug/ml, ferri-
tin 57798 ng/ml, ALT 152 U/l, AST 387 U/l. Natural
killer (NK) cells were found 1.2 % (normal range 5-23%).
Tacrolimus level was severely toxic (> 30 ng/ml) so treat-
ment withdrawn. IV methylprednisolone was adminis-
tered at a dose of 30 mg/kg/day for three days and
switched to prednisolon 2 mg/kg/day. After the tacroli-
mus level decreased to 5 ng/ml, cyclosporine 5 mg/kg
was added. During that time Hb was 9.55 g/dL, WBC
5220/mm3, plt 21800/mm3, ESR 2 mm/h, CRP
0.13 mg/dl, fibrinogen 1.9 g/l, D-dimer mmax. She was
developed headache and dizziness. Because suspicion of
central nervous system involment, anti thymocyte globu-
lin (ATG) was administered. MRI which was reported as
normal, could be performed the next day. ATG therapy
continued because of persisting laboratory findings of
MAS. In the fifth day of ATG therapy Hb was 9.41 g/dL,
WBC 22000/mm3, plt 117000/mm3, ESR 2 mm/h, CRP
0.36 mg/dl, fibrinogen 1.1 g/l, D-dimer 1.1 ug/ml, ferritin
1381 ng/ml. Anakinra (1 mg/kg/day) was obtained and
added to therapy. After -45- days follow up, she was dis-
charged with prednisolon, cyclosporine and anakinra.
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Conclusion
MAS due to soJIA in a liver transplant patient; although
diagnosed in the early phase of the disease, revealed dif-
ficulties in the management. Treatment with drugs pro-
posed for hemophagocytic lymphohistiocytosis and
increased dosage of tacrolimus did not sustained remis-
sion. The patient improved with cyclosporine and ATG.
It is emphasized that MAS due to soJIA should be trea-
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